IOVA - Iovance Biotherapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$2.00
DETAILS
HIGH:
$2.00
LOW:
$2.00
MEDIAN:
$2.00
CONSENSUS:
$2.00
DOWNSIDE:
51.22%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||
| Revenue | 263.5 | 164.1 | 1.2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 7.3 | 124.0 | 10.8 | 0 | 0 | 0 | 8.1 | 1.0 | 1.0 | 1.0 | 1.0 | 0.1 | 4.7 | 6.5 | 19.3 | 0 | 0.0 | 0 |
| Gross Profit | 256.2 | 40.1 | (9.6) | 0 | 0 | 0 | (8.1) | (1.0) | (1.0) | (1.0) | (1.0) | (9.3) | (4.7) | (6.5) | (19.3) | 0 | 0 | 0 |
| Operating Expenses | ||||||||||||||||||
| R&D Expenses | 300.3 | 282.3 | 344.1 | 294.8 | 259.0 | 201.7 | 166.0 | 99.8 | 71.6 | 28.0 | 15.5 | 2.7 | 1.3 | 1.7 | 1.8 | 0 | 0 | 0 |
| SG&A Expenses | 152.3 | 153.0 | 106.9 | 104.1 | 83.7 | 60.2 | 40.8 | 28.4 | 21.3 | 17.2 | 12.4 | 9.3 | 4.7 | 6.5 | 19.3 | 0.8 | 0.0 | 0.0 |
| Other Expenses | 207.0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9.5 | 0 | 0 | 16.7 | 0 | 0.2 | 0.8 | 0 | 0 |
| Operating Expenses | 659.6 | 435.4 | 451.0 | 398.9 | 342.7 | 261.9 | 206.9 | 128.3 | 92.9 | 53.6 | 27.9 | 2.7 | 18.0 | 8.1 | 1.9 | 0.8 | 0.0 | 0.1 |
| Operating Income | ||||||||||||||||||
| Operating Income | (403.4) | (395.3) | (460.6) | (398.9) | (342.7) | (261.9) | (206.9) | (128.3) | (92.9) | (53.6) | (27.9) | (12.0) | (22.6) | (8.1) | (21.2) | (0.8) | (0.0) | (0.1) |
| Interest Expense | 0 | 0 | 0 | 3.0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.2 | 0.0 | 0.4 | 2.4 | 0.2 | 0 | 0 | 0 |
| Interest Income | 0 | 20.3 | 13.0 | 3.0 | 0.5 | 2.4 | 9.3 | 0 | 0.8 | 0.7 | 0.2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profitability | ||||||||||||||||||
| EBITDA | (357.1) | (351.7) | (427.4) | (377.7) | (328.7) | (260.8) | (189.4) | (122.6) | (91.1) | (51.9) | (26.7) | (11.9) | (24.9) | 0.5 | (20.5) | (1.5) | (0.0) | (0.1) |
| EBIT | (393.0) | (395.3) | (460.6) | (398.9) | (342.7) | (261.9) | (197.6) | (123.6) | (92.1) | (52.9) | (27.7) | (12.0) | (24.9) | 0.5 | (20.5) | (1.6) | (0.0) | (0.1) |
| Income Before Tax | (393.0) | (375.0) | (447.5) | (395.9) | (342.3) | (259.6) | (197.6) | (123.6) | (92.1) | (52.9) | (27.7) | (12.0) | (25.4) | (3.3) | (25.7) | (1.6) | (0.0) | (0.1) |
| Income Tax Expense | (2.1) | (2.8) | (3.5) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | (391.0) | (372.2) | (444.0) | (395.9) | (342.3) | (259.6) | (197.6) | (123.6) | (92.1) | (52.9) | (27.7) | (12.0) | (25.4) | (3.3) | (25.7) | (1.6) | (0.0) | (0.1) |
| Per Share Data | ||||||||||||||||||
| EPS (Basic) | -1.09 | -1.28 | -1.89 | -2.49 | -2.23 | -1.88 | -1.50 | -1.27 | -1.41 | -0.96 | -0.62 | -0.48 | -2.60 | -4.14 | -33.84 | -2.46 | -0.02 | -0.05 |
| EPS (Diluted) | -1.09 | -1.28 | -1.89 | -2.49 | -2.23 | -1.88 | -1.50 | -1.27 | -1.41 | -0.96 | -0.62 | -0.48 | -2.60 | -4.14 | -33.84 | -2.46 | -0.02 | -0.05 |
| Shares Outstanding | 357.3 | 289.9 | 235.1 | 159.3 | 153.4 | 138.3 | 124.3 | 97.3 | 65.2 | 55.3 | 44.4 | 25.0 | 9.8 | 0.8 | 0.8 | 0.7 | 0.9 | 1.2 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||||||
| Cash & Cash Equivalents | 163.1 | 115.7 | 114.9 | 231.7 | 78.2 | 67.3 | 14.0 | 82.2 | 145.4 | 166.5 | 0.0 | 0.0 |
| Short-Term Investments | 133.9 | 208.1 | 165.0 | 240.1 | 426.2 | 562.1 | 293.1 | 386.4 | 0 | 0 | 0 | 0 |
| Net Receivables | 82.4 | 69.3 | 0.2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory | 51.7 | 51.5 | 10.4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 11.6 | 12.4 | 17.5 | 7.3 | 0 | 0 | 0 | 6.9 | 3.9 | 3.0 | 0.0 | 0.0 |
| Total Current Assets | 442.7 | 457.0 | 307.8 | 479.1 | 508.0 | 636.1 | 316.5 | 475.4 | 149.3 | 169.5 | 0.0 | 0.0 |
| Non-Current Assets | ||||||||||||
| Property, Plant & Equipment | 177.0 | 164.3 | 176.5 | 178.2 | 169.9 | 113.9 | 19.2 | 2.7 | 2.5 | 2.4 | 0 | 0.0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 279.3 | 282.4 | 229.3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.0 | 0 |
| Long-Term Investments | 0 | 0 | 66.4 | 0 | 91.6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 14.1 | 6.7 | 0.3 | 6.6 | 7.9 | 18.4 | 8.9 | 2.8 | 3.6 | 0 | 0 | 0 |
| Total Non-Current Assets | 470.5 | 453.4 | 472.5 | 184.9 | 269.4 | 132.4 | 28.2 | 5.4 | 6.1 | 2.4 | 0.0 | 0.0 |
| Total Assets | 913.2 | 910.4 | 780.4 | 664.0 | 777.3 | 768.5 | 344.7 | 480.8 | 155.4 | 171.9 | 0.0 | 0.0 |
| Current Liabilities | ||||||||||||
| Account Payables | 22.2 | 27.5 | 33.1 | 26.6 | 27.4 | 13.5 | 15.6 | 2.7 | 1.2 | 0.9 | 0 | 0 |
| Short-Term Debt | 4.0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 112.2 | 50.0 | 34.6 | 0 | 0 | 0 | 0 | 7.5 | 5.8 | 2.5 | 0 | 0 |
| Total Current Liabilities | 138.4 | 122.3 | 110.3 | 91.5 | 89.2 | 54.9 | 39.1 | 14.4 | 9.9 | 5.0 | 0.0 | 0.0 |
| Non-Current Liabilities | ||||||||||||
| Long-Term Debt | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 31.8 | 32.3 | 17.3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 11.7 | 2.4 | 0.2 | 0.3 | 0 | 0 | 0 |
| Total Non-Current Liabilities | 76.2 | 77.7 | 85.4 | 72.9 | 66.5 | 57.1 | 6.6 | 0.2 | 0.3 | 0 | 0 | 0 |
| Total Liabilities | 214.6 | 200.0 | 195.7 | 164.3 | 155.7 | 112.0 | 45.7 | 14.6 | 9.9 | 5.0 | 0.0 | 0.0 |
| Stockholders' Equity | ||||||||||||
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Retained Earnings | (2,775.5) | (2,384.6) | (2,012.4) | (1,568.3) | (1,172.4) | (830.2) | (570.6) | (372.8) | (249.2) | (157.1) | (0.1) | (0.1) |
| Accumulated Other Comprehensive Income | 16.4 | (1.0) | 2.5 | (0.9) | (0.6) | 0.0 | 0.2 | (0.0) | 0 | 0.0 | 0 | 0 |
| Total Stockholders' Equity | 698.6 | 710.4 | 584.6 | 499.6 | 621.7 | 656.5 | 299.0 | 466.2 | 145.5 | 166.9 | (0.0) | 0.0 |
| Total Liabilities & Equity | 913.2 | 910.4 | 780.4 | 664.0 | 777.3 | 768.5 | 344.7 | 480.8 | 155.4 | 171.9 | 0.0 | 0.0 |
| Debt Metrics | ||||||||||||
| Total Debt | 48.4 | 58.3 | 75.9 | 85.4 | 71.5 | 51.7 | 11.5 | 0 | 0 | 0 | 0 | 0 |
| Net Debt | (114.6) | (57.4) | (39.0) | (146.3) | (6.7) | (15.7) | (2.5) | (82.2) | (145.4) | (166.5) | (0.0) | (0.0) |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||
| Net Income | (391.0) | (372.2) | (444.0) | (395.9) | (342.3) | (259.6) | (197.6) | (123.6) | (92.1) | (52.9) |
| Depreciation & Amortization | 34.5 | 43.6 | 33.1 | 21.1 | 14.0 | 1.1 | 8.1 | 1.0 | 1.0 | 1.0 |
| Stock-Based Compensation | 61.6 | 109.6 | 62.6 | 84.0 | 69.8 | 40.9 | 24.3 | 20.0 | 12.0 | 18.9 |
| Change in Working Capital | (24.3) | (122.6) | (6.5) | (2.9) | 24.6 | 3.0 | (2.7) | 2.7 | 0.4 | 0.4 |
| Other Non-Cash Items | 18.9 | (8.6) | (3.5) | 0.9 | 6.0 | 7.6 | 9.0 | (1.3) | 0.0 | (0.1) |
| Operating Cash Flow | (302.4) | (353.0) | (361.8) | (292.8) | (227.9) | (205.1) | (158.9) | (101.2) | (78.7) | (32.7) |
| Investing Activities | ||||||||||
| Capital Expenditure | (33.8) | (11.1) | (22.3) | (20.4) | (37.6) | (46.8) | (6.9) | (1.2) | (1.0) | (1.5) |
| Acquisitions | 0 | (52.6) | (212.6) | (276.9) | (37.7) | 271.1 | 0 | 0 | 0 | 0 |
| Purchases of Investments | (318.7) | (460.8) | (205.9) | (245.8) | (725.2) | (947.7) | 0 | (426.1) | 0 | (110.2) |
| Sales/Maturities of Investments | 400 | 428 | 285.6 | 522.7 | 762.9 | 676.6 | 0 | 41 | 59.7 | 120.7 |
| Other Investing Activities | 0 | 0 | 0 | 276.9 | 37.7 | (271.1) | 96.9 | (385.1) | 59.7 | 10.4 |
| Investing Cash Flow | 47.5 | (96.4) | (155.2) | 256.5 | 0.1 | (317.9) | 90.0 | (386.3) | 58.7 | 8.9 |
| Financing Activities | ||||||||||
| Net Debt Issuance | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
| Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | (0.3) | 0 | (1.3) | (0.6) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (49.5) |
| Other Financing Activities | (7.1) | (6.6) | (0.3) | 0.6 | 35.1 | 9.4 | 6.4 | (373.3) | 5.0 | 50.7 |
| Financing Cash Flow | 300.8 | 390.7 | 463.0 | 190.2 | 239.3 | 576.4 | 6.1 | 424.3 | 58.7 | 96.9 |
| Cash Position | ||||||||||
| Net Change in Cash | 47.4 | (59.3) | (56.8) | 153.8 | 11.5 | 53.4 | (62.7) | (63.2) | 38.7 | 73.1 |
| Cash at Beginning | 122.1 | 181.3 | 238.2 | 84.3 | 72.9 | 19.4 | 82.2 | 145.4 | 106.7 | 33.6 |
| Cash at End | 169.1 | 122.1 | 181.3 | 238.2 | 84.3 | 72.9 | 19.4 | 82.2 | 145.4 | 106.7 |
| Free Cash Flow | (336.2) | (364.0) | (384.1) | (313.2) | (265.5) | (251.9) | (165.8) | (102.4) | (79.7) | (34.2) |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||||||||||
| Revenue | 263.5 | 164.1 | 1.2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 256.2 | 40.1 | (9.6) | 0 | 0 | 0 | (8.1) | (1.0) | (1.0) | (1.0) | (1.0) | (9.3) | (4.7) | (6.5) | (19.3) | 0 | 0 | 0 |
| Operating Income | (403.4) | (395.3) | (460.6) | (398.9) | (342.7) | (261.9) | (206.9) | (128.3) | (92.9) | (53.6) | (27.9) | (12.0) | (22.6) | (8.1) | (21.2) | (0.8) | (0.0) | (0.1) |
| Net Income | (391.0) | (372.2) | (444.0) | (395.9) | (342.3) | (259.6) | (197.6) | (123.6) | (92.1) | (52.9) | (27.7) | (12.0) | (25.4) | (3.3) | (25.7) | (1.6) | (0.0) | (0.1) |
| EPS (Diluted) | -1.09 | -1.28 | -1.89 | -2.49 | -2.23 | -1.88 | -1.50 | -1.27 | -1.41 | -0.96 | -0.62 | -0.48 | -2.60 | -4.14 | -33.84 | -2.46 | -0.02 | -0.05 |
| Balance Sheet | ||||||||||||||||||
| Cash & Equivalents | 163.1 | 115.7 | 114.9 | 231.7 | 78.2 | 67.3 | 14.0 | 82.2 | 145.4 | 166.5 | 0.0 | 0.0 | ||||||
| Total Assets | 913.2 | 910.4 | 780.4 | 664.0 | 777.3 | 768.5 | 344.7 | 480.8 | 155.4 | 171.9 | 0.0 | 0.0 | ||||||
| Total Debt | 48.4 | 58.3 | 75.9 | 85.4 | 71.5 | 51.7 | 11.5 | 0 | 0 | 0 | 0 | 0 | ||||||
| Stockholders' Equity | 698.6 | 710.4 | 584.6 | 499.6 | 621.7 | 656.5 | 299.0 | 466.2 | 145.5 | 166.9 | (0.0) | 0.0 | ||||||
| Cash Flow | ||||||||||||||||||
| Operating Cash Flow | (302.4) | (353.0) | (361.8) | (292.8) | (227.9) | (205.1) | (158.9) | (101.2) | (78.7) | (32.7) | ||||||||
| Capital Expenditure | (33.8) | (11.1) | (22.3) | (20.4) | (37.6) | (46.8) | (6.9) | (1.2) | (1.0) | (1.5) | ||||||||
| Free Cash Flow | (336.2) | (364.0) | (384.1) | (313.2) | (265.5) | (251.9) | (165.8) | (102.4) | (79.7) | (34.2) | ||||||||